Hers: Women’s Healthcare
By Hims & Hers
Hers: Women’s Healthcare is a telemedicine app for women providing prescription treatments for weight loss, hair growth, and menopause on iOS and Android.
The App DNA
What makes this app unique?
The app removes the time and travel costs of in-person doctor visits for recurring prescription needs, providing a centralized dashboard for treatment management.
For Women seeking convenient, remote access to prescription treatments for weight loss, hair growth, menopause, and mental health.
What does it look like?
Key features
Direct access to licensed medical providers via video, phone, or live chat.
Step-by-step guided content and coaching for the first 4 weeks of a treatment plan.
At-home lab testing kits with doctor-developed action plans based on results.
How much does it cost?
Monetization relies on recurring subscription revenue for prescription treatments and health programs, supplemented by direct retail sales in the member shop.
Velocity
Intense developmentShow more...
5 versions in history. Development pace: intense.
Who built it?
Hims & Hers
5 apps tracked · Medical
Hims: Telehealth for Men
Hims & Hers
Hers: Women’s Healthcare
Hims: Telehealth for MenUser Sentiment
What do users think recently?
Fresh user feedback skews frustrated. Users appreciate hair growth treatments provide visible results for users after several months of consistent daily application.
How are ratings & reviews evolving?
What users say, by theme
- Hair growth treatments provide visible results for users after several months of consistent daily application
- Technical failures during login and app navigation prevent users from accessing their prescribed care plans
49 of 49 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Hers: Women’s Healthcare
How's the Medical market?
Hers: Women’s Healthcare holds a #97 rank in Health & Fitness on the US App Store. The 0.66 rating gap between iOS and Android platforms highlights a significant disparity in technical stability that limits the app's reach on the Android segment.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Hers: Women’s Healthcare
Where is it heading?
The telemedicine market is shifting toward higher expectations for digital reliability, and Hers: Women’s Healthcare is currently failing to meet these standards. Without a stabilization of the app's login and billing flows, the brand will likely see continued erosion of its user base despite the efficacy of its medical treatments.
- Persistent login failures in the latest version prevent users from accessing their care plans, which directly increases churn risk.
- Aggressive billing practices and lack of refund options for unused medications are driving negative sentiment and damaging the brand.
The SWOT
- Direct access to licensed medical providers via video or chat
- Structured 4-week treatment coaching programs reduce abandonment
- Implement a home screen widget to improve daily medication adherence
- Expand lab testing action plans to drive higher-value recurring revenue
Next best moves
Rebuild the login and navigation flow because technical failures prevent access to care plans → reduce churn
+ 1 more prioritized moveThe counter-intuitive read
The high volume of billing complaints suggests that Hers…
Read the full takeSince the last report: The platform transitioned from a basic telehealth provider to a specialized care model by adding guided treatment programs and lab testing, while simultaneously suffering from increased user friction related to login stability and billing practices.
Bottom line
Hers: Women’s Healthcare must prioritize technical stability and billing transparency to protect its subscription revenue, as the current digital friction is eroding the trust required for long-term patient retention.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated